ATARA BIOTHERAPEUTICS, INC. Other Accrued Liabilities, Current
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Other Accrued Liabilities, Current of $208.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Other Accrued Liabilities, Current $208.00K.
- 2026-03-31: Other Accrued Liabilities, Current $171.00K.
- 2025-12-31: Other Accrued Liabilities, Current $150.00K.
- 2025-09-30: Other Accrued Liabilities, Current $144.00K.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $208.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $171.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $150.00K 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $144.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $646.00K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $729.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $216.00K 10-K · filed 2026-03-16 | $598.00K 10-K · filed 2025-03-07 |
| 2024-09-30 | $927.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $963.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $812.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $640.00K 10-K · filed 2025-03-07 | |
| 2023-09-30 | $211.00K 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $931.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $482.00K 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $319.00K 10-K · filed 2024-03-28 | |
| 2021-12-31 | $344.00K 10-K · filed 2023-02-08 | |
| 2020-12-31 | $1.06M 10-K · filed 2022-02-28 | |
| 2019-12-31 | $252.00K 10-K · filed 2021-03-01 | |
| 2018-12-31 | $200.00K 10-K · filed 2020-02-27 | |
| 2017-09-30 | $1.85M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $905.00K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $886.00K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $744.00K 10-Q · filed 2017-11-09 | |
| 2016-09-30 | $960.00K 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $837.00K 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $1.20M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $528.00K 10-K · filed 2017-03-09 | |
| 2015-09-30 | $3.03M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $4.52M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $2.20M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $235.00K 10-K · filed 2016-03-04 | $1.06M 10-K · filed 2015-02-26 |
| 2014-09-30 | $1.28M 10-Q · filed 2014-11-12 | |
| 2013-12-31 | $432.00K 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |